echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > "Great health" is becoming the next hot outlet, and the market is showing a storm

    "Great health" is becoming the next hot outlet, and the market is showing a storm

    • Last Update: 2018-12-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    [China Pharmaceutical network industry trends] on the evening of December 24, SAPS announced that Chen Dekang, the controlling shareholder of the company, intends to transfer 31154075 shares of the company's unlimited sale and circulation (accounting for 9.66% of the company's total share capital) to Shanghai Yanghe Investment Management Co., Ltd The total transfer price of this transaction is about 260 million yuan, and the transfer price is 8.33 yuan / share After this equity change, Chen Dekang held 28.97% of the company's total share capital The controlling shareholders and actual controllers of the company remain unchanged It is reported that the business scope of Shanghai Yanghe Investment Management Co., Ltd includes investment management, consultation, industrial investment, hospital investment management, market information consultation and investigation, especially focusing on the investment in the medical industry and the establishment of relevant databases The news of this equity change of saps pharmaceutical industry quickly raised waves in the industry As early as 2017, SAPS pharmaceutical has publicly proposed the corporate strategy of "big health" transformation And in the past two years, the company has frequently acted in the field of layout health In August 2018, Chen Dekang, chairman of the company, made clear the future development direction at the "work summary and innovation and Development Conference for the 40th anniversary of sepsis pharmaceutical industry": in the future, the company will still adhere to independent innovation and actively layout the OTC big health field At the 2018 Boao Forum of Chinese entrepreneurs in December, sapais pharmaceutical also said that to promote people's health and industry health, the basic problem for pharmaceutical enterprises is to reduce intervention, which is the core demand in the field of big health, and big data is a more direct way to reduce intervention It is reported that at present, SAPS pharmaceutical industry has carried out relevant layout in big data and Internet artificial intelligence, focusing on building information database for middle-aged and elderly people, establishing member system, focusing on sub-health field, so as to better complete prevention work and put an end to the occurrence of related chronic diseases In conclusion, the transfer of shares to Shanghai Yanghe is also revealing the information that the era of "great health" has come, and the database will become a powerful measure for Hong Kong enterprises to maintain their core competitiveness The industry said that nowadays, with the rapid development of domestic economy and the improvement of people's living standards, people will invest more and more in health, as well as a number of support from the national policy on "implementing the health China strategy", China's large-scale health industry is ushering in the spring of development According to the public data, in 2013, the scale of China's large-scale health industry is close to 5 trillion yuan, accounting for 8% of the total GDP By 2020, the total scale of China's health industry will exceed 8 trillion yuan By 2023, the scale of large-scale health industry is expected to exceed 20 trillion yuan It can be seen that the big health industry is becoming the next hot outlet In this context, the market has been hidden thunder, and how to seize the industry's commanding height is a key The author has learned that some domestic pharmaceutical enterprises have transformed into the field of big health, and there are some parts For example, with the gradual coverage of digital technology, Kangmei pharmaceutical industry relies on the resource advantages of traditional Chinese medicine industry to build a new model of "big health + big platform + big data + big service" With the help of intelligent technology, we will build a "smart +" health platform with smart pharmacy, smart medicine cabinet and medicine gourd as the core, and keep up with the development theme of the times According to the industry, with the continuous occurrence of big data, intelligent manufacturing, cloud computing and other technologies, the industrial structure of big health will also undergo profound changes.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.